These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21135826)

  • 21. [HIV antiretroviral agents: new threats to accessibility in developing countries].
    Nau JY
    Rev Med Suisse; 2005 Dec; 1(45):2956. PubMed ID: 16425957
    [No Abstract]   [Full Text] [Related]  

  • 22. Access to essential medicines: a Hobbesian social contract approach.
    Ashcroft RE
    Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intellectual property rights and right of access to medicines].
    Velásquez G
    Med Trop (Mars); 2006 Dec; 66(6):526-8. PubMed ID: 17286013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ownership of knowledge--the role of patents in pharmaceutical R&D.
    Correa CM
    Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assuring access to quality antiretroviral medicines: the WHO Prequalification of Medicines Program and access to HIV treatment.
    t'Hoen E
    Cad Saude Publica; 2014 May; 30(5):908-9. PubMed ID: 24936808
    [No Abstract]   [Full Text] [Related]  

  • 26. Scaling up AIDS treatment: what is the potential impact and what are the risks?
    Lamptey P; Wilson D
    PLoS Med; 2005 Feb; 2(2):e39. PubMed ID: 15740413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care.
    Bedelu M; Ford N; Hilderbrand K; Reuter H
    J Infect Dis; 2007 Dec; 196 Suppl 3():S464-8. PubMed ID: 18181695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation.
    Ojikutu B
    J Infect Dis; 2007 Dec; 196 Suppl 3():S445-8. PubMed ID: 18181692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trips and public health: solutions for ensuring global access to essential AIDS medication in the wake of the Paragraph 6 Waiver.
    Greenbaum JL
    J Contemp Health Law Policy; 2008; 25(1):142-65. PubMed ID: 19137750
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand.
    Supakankunti S; Janjaroen WS; Tangphao O; Ratanawijitrasin S; Kraipornsak P; Pradithavanij P
    Bull World Health Organ; 2001; 79(5):461-70. PubMed ID: 11417042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy for AIDS: affordable and accessible.
    Kalantri SP
    Natl Med J India; 2004; 17(3):179. PubMed ID: 15253413
    [No Abstract]   [Full Text] [Related]  

  • 32. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
    Ghosh S
    Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
    [No Abstract]   [Full Text] [Related]  

  • 33. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
    Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
    AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
    [No Abstract]   [Full Text] [Related]  

  • 34. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
    Curti AM
    Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
    [No Abstract]   [Full Text] [Related]  

  • 35. Global coalition aims to ramp up ARV access.
    d'Adesky AC
    AIDS; 2003; 17 Suppl 4():S3. PubMed ID: 15080169
    [No Abstract]   [Full Text] [Related]  

  • 36. Science and the law. Working through the patent problem.
    Walsh JP; Cohen WM; Arora A
    Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
    [No Abstract]   [Full Text] [Related]  

  • 37. [The patent legislation in India fails the HIV/AIDS work].
    Holen Ø
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
    [No Abstract]   [Full Text] [Related]  

  • 38. Generic and branded drugs for the treatment of people living with HIV/AIDS.
    Bartlett JA; Muro EP
    J Int Assoc Physicians AIDS Care (Chic); 2007 Mar; 6(1):15-23. PubMed ID: 17329500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Could AIDS treatments slip through patents loophole?
    Smaglik P
    Nature; 2000 Mar; 404(6776):322. PubMed ID: 10746692
    [No Abstract]   [Full Text] [Related]  

  • 40. Intellectual property rights, compulsory licensing and the TRIPS agreement: some ethical issues.
    Schuklenk U
    Monash Bioeth Rev; 2003 Apr; 22(2):63-8. PubMed ID: 15069958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.